Alignment Healthcare (ALHC) EBIT Margin (2020 - 2025)
Alignment Healthcare's EBIT Margin history spans 6 years, with the latest figure at 0.99% for Q4 2025.
- For Q4 2025, EBIT Margin rose 238.0% year-over-year to 0.99%; the TTM value through Dec 2025 reached 0.37%, up 421.0%, while the annual FY2025 figure was 0.37%, 417.0% up from the prior year.
- EBIT Margin reached 0.99% in Q4 2025 per ALHC's latest filing, down from 0.77% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 2.26% in Q2 2025 to a low of 19.72% in Q1 2021.
- Average EBIT Margin over 5 years is 6.97%, with a median of 6.56% recorded in 2024.
- Peak YoY movement for EBIT Margin: plummeted -2020bps in 2021, then surged 1130bps in 2022.
- A 5-year view of EBIT Margin shows it stood at 14.55% in 2021, then increased by 1bps to 14.37% in 2022, then skyrocketed by 39bps to 8.7% in 2023, then skyrocketed by 61bps to 3.37% in 2024, then surged by 71bps to 0.99% in 2025.
- Per Business Quant, the three most recent readings for ALHC's EBIT Margin are 0.99% (Q4 2025), 0.77% (Q3 2025), and 2.26% (Q2 2025).